Is it a supplementary benefit to use anti-inflammatory agents in the treatment of type 2 diabetes?
Crossref DOI link: https://doi.org/10.1186/s13104-017-2785-4
Published Online: 2017-09-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Patrice, Nzogang K.
Martial, Donkeng J.
Bruno, Telefo P.